Device Bone Substitute

Tornier Perform Anatomic Augmented Glenoid

Payments companies reported to CMS as associated with Tornier Perform Anatomic Augmented Glenoid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.7Massociated payments (2023-2025)
249clinicians with associated payments
1company reporting

By year

2023 $479K
2024 $1.0M
2025 $220K

Payments reported as associated with Tornier Perform Anatomic Augmented Glenoid, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $1.3M
Sports Medicine (Orthopaedic Surgery) $341K
Adult Reconstructive Orthopaedic Surgery $37K
Hand Surgery $15K
Orthopaedic Trauma $4,094
Surgical $707

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Tornier Perform Anatomic Augmented Glenoid

These are the largest totals companies reported as associated with Tornier Perform Anatomic Augmented Glenoid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mark Mighell Temple Terrace, FL Orthopaedic Surgery $117,260.02
James Gregory Houston, TX Sports Medicine (Orthopaedic Surgery) $109,615.37
Robert Tashjian Salt Lake City, UT Orthopaedic Surgery $104,343.85
Jay Keener Saint Louis, MO Orthopaedic Surgery $93,580.00
Vahid Entezari Philadelphia, PA Orthopaedic Surgery $87,987.50
Joaquin Sanchez-Sotelo Rochester, MN Orthopaedic Surgery $78,210.00
Jon Warner Boston, MA Orthopaedic Surgery $71,665.50
Benjamin Service Orlando, FL Orthopaedic Surgery $47,818.61
Dane Salazar Maywood, IL Orthopaedic Surgery $47,153.41
Catherine Fedorka Camden, NJ Orthopaedic Surgery $42,706.25

Prescribed Tornier Perform Anatomic Augmented Glenoid?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.